| DRMA Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||
Below is a table of the DRMA market cap history going back to 11/10/2021:
Also see: DRMA Shares Outstanding History and DRMA YTD Return |
DRMA Market Cap History — Dermata Therapeutics Capitalization Over Time
As of 5/12/2026 Dermata Therapeutics has a market cap of 4.99 million. Investors often follow the DRMA market cap history to compare the size of the company over time.
This page shows DRMA market capitalization trends over time, with 19 market cap datapoints presented, dating back to 11/10/2021.
| DRMA Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||
DRMA Historical Market Cap: -37.81% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||
| DRMA Stock Price Chart |
| About Dermata Therapeutics Inc |
| Dermata Therapeutics, Inc. is a late-stage medical dermatology company. Co. is focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, both incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its lead product candidate, DMT310, is intended to utilize its Spongilla technology for once weekly treatment of a variety of skin diseases, with its initial focus being the treatment of acne vulgaris, which has a U.S. market size of approximately 50 million patients. We show 19 historical shares outstanding datapoints in our DRMA shares outstanding history coverage, used to compute DRMA market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing DRMA market cap history over the course of time is important for investors interested in comparing DRMA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of DRMA versus a peer is one thing; comparing DRMA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like DRMA can fluctuate over the course of history. With this page we aim to empower investors researching DRMA by allowing them to research the DRMA market cap history. |
| DRMA Current Stock Quote |
Quotes delayed 20 minutes  Free DRMA Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| DRMA Share Performance |
| Market Cap Peers |
| Dermata Therapeutics (DRMA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
DRNA Market Cap History DRRX Market Cap History DSGN Market Cap History DTIL Market Cap History DVA Market Cap History DVAX Market Cap History DVCR Market Cap History DWTX Market Cap History DXCM Market Cap History DYAI Market Cap History More Healthcare companies » |
DRMA Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
